Drug Trial Radar · NCT03769194
Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.
Last checked: Nov 19, 2026Latest source record: Jan 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
572
Actual
Start
Dec 17, 2018
Primary completion
Dec 18, 2019
Study completion Oct 2, 2020
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Dec 7, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomized, observer-blind, placebo controlled, multicenter Phase 2 study conducted in two study phases: a run-in phase and a main study phase. The study was investigated 3 doses of a multivalent OspA (Outer Surface Protein A) based Lyme vaccine (VLA15) in healthy adults aged 18 to 65 years of age. Study participants received 3 immunizations of the vaccine at a monthly interval. The study assessed the immune response as well as the safety profile of the vaccine.
Conditions
- Lyme Borreliosis
Interventions
VLA15Biological
a multivalent recombinant Outer surface protein A (OspA) based vaccine candidate
PlaceboBiological
Placebo: PBS (Phosphate Buffered Saline)
Primary outcomes
What the sponsor says the trial is designed to measure.
- GMTs (Geometric Mean Titers) for IgG (Immunoglobulin G) Against Each OspA (Outer Surface Protein A) Serotype ST1 to ST6Time frame: at Day 85 / Month 3
Locations
9 sites in 3 countries. Site status is shown where the registry gives one.
Clinical Research Consulting, LLC
Milford, Connecticut
Stamford Therapeutics Consortium
Stamford, Connecticut
United Medical Associates
Binghamton, New York
Regional Clinical Research, Inc.
Endwell, New York
Rochester Clinical Research Inc.
Rochester, New York
Omega Medical Research
Warwick, Rhode Island
Cevac Center for vaccinology
Ghent, Belgium
Berliner Centrum für Reise- und Tropenmedizin (BCRT)
Berlin, Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.